Hanneke Schuitemaker
Johnson & Johnson (Israel)(IL)Johnson & Johnson (Netherlands)(NL)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, Immune Cell Function and Interaction, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19(2021)2,574 cited
- → Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine(2021)1,161 cited
- → Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population(1992)1,035 cited
- → Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques(2020)900 cited
- → A new classification for HIV-1(1998)825 cited
- → Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule(1992)768 cited